Biomarker: F081-IgE Cheese, Cheddar Type

Overview

F081-IgE Cheese, Cheddar Type measures immunoglobulin E (IgE) antibodies in blood that recognize proteins in cheddar-type cheese, primarily milk casein and whey proteins. IgE is involved in immediate allergic reactions by activating immune cells that release mediators such as histamine. A detectable or elevated result indicates sensitization to the tested cheese extract, while a low or undetectable result makes sensitization less likely but does not completely exclude clinical allergy. The test supports evaluation of suspected IgE-mediated cow’s-milk or cheese allergy, but the result alone cannot establish allergy, predict reaction severity, or determine whether a person will react when eating cheddar cheese.

Clinical Use Cases

Supports evaluation of immediate symptoms after eating cheddar cheese or other dairy products, including hives, swelling, wheezing, vomiting, or anaphylaxis.
Helps identify sensitization to cheese proteins when interpreted with the clinical history.
May support evaluation of suspected cow’s-milk allergy involving casein or whey proteins.
Helps guide referral to an allergy specialist and selection of further testing.
May be used alongside skin-prick testing, component testing, and, when clinically appropriate, a supervised oral food challenge.
Does not independently confirm food allergy or establish the severity of a potential reaction.

Specimen Types

Venous blood.
Serum.
Plasma may be accepted by some validated assay systems.

Measurement Methods

Allergen-specific IgE immunoassay using cheddar cheese or related milk-protein allergen extract.
Fluorescence enzyme immunoassay, including solid-phase assays such as ImmunoCAP.
Other validated enzyme-linked or chemiluminescent immunoassays.
Results are commonly reported quantitatively in kUA/L and/or semiquantitatively by class, depending on the assay.

Test Preparation and Influencing Factors

Fasting is generally not required for a specific-IgE blood test, unless other tests collected at the same time require fasting.
Patients should report prescription medicines, over-the-counter medicines, and supplements. Medicines should not be stopped unless instructed by a healthcare professional.
Antihistamines generally do not affect blood specific-IgE measurements, although they can interfere with skin-prick testing. Follow the ordering clinician’s instructions if multiple allergy tests are planned.
Recent exposure to cheddar cheese is not usually required before blood collection.
Timing after a recent allergic reaction may affect results in some patients; the treating clinician may recommend repeat testing if clinical suspicion remains high.
Total IgE, age, atopic conditions, cross-sensitization, assay selection, and the specific cheese extract can influence interpretation.
A positive result indicates IgE sensitization, not necessarily clinically important allergy. Results must be interpreted with the exposure history and symptoms.
Specific-IgE concentration does not reliably predict reaction severity.
A supervised oral food challenge remains the reference method when the diagnosis is uncertain and must be performed by trained medical personnel.